 |
|
|
| Stem cell transplantations - Clinical 2 |
| Date: | Saturday, 8 June 2002 |
| Time: | 11:30-12:45 |
| Room: | Michelangelo |
| 11:30-11:45 |
0577 |
|
|
HIGH-DOSE THERAPY INTENSIFICATION VERSUS CONTINUED CHEMOTHERAPY IN RESPONDING MULTIPLE MYELOMA PATIENTS. RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL FROM THE SPANISH COOPERATIVE GROUP PETHEMA
J. Bladé, A. Sureda, J.M. Ribera, J. Díaz-Mediavilla, J. García-Laraña, L. Palomera, J. Fernández-Calvo, J.M. Martí, P. Giraldo, F. Carbonell, M. Callís, J. Trujillo, S. Gardella, M.J. Moro, A. Barez, J.F. San Miguel (Barcelona, Spain)
| 11:45-12:00 |
0578 |
|
|
High-Dose Melphalan and Second Autografts for Myeloma Relapsing after One Autograft: Results Equivalent to Tandem Autotransplantation
B.S. Sirohi, R. Powles, S. Singhal, J. Treleaven, R. Saso, S. Kulkarni, C. Horton, S. Goyal, S. Sankpal, J. Mehta (Surrey, United Kingdom)
| 12:00-12:15 |
0579 |
|
|
Effect of cell dose on outcome of children with acute lymphoblastic leukaemia given an unrelated donor bone marrow transplantation
F. Locatelli, M. Labopin, J. Cornish, V. Rocha, U. Pihkala, E. Lanino, T. Carr, C. Peters, J. Ortega, D. Niethammer, F. Frassoni (Pavia, Italy)
| 12:15-12:30 |
0580 |
|
|
Fludarabine melphalan is a suitable alternative to fludarabine TBI-based conditioning for allogeneic transplantation in high-risk patients with advanced haematological malignancies
K. van Besien, S. Devine, E. Wickrema, E. Jessop, K. Amin, M. Yassine, W. Stock, D. Peace, F. Ravandi, H.Y. Chen, T. Cheung, S. Vijayakumar, J. Sosman (Chicago, United States of America)
| 12:30-12:45 |
0581 |
|
|
Intensive versus double intensive therapy in untreated Multiple Myeloma: a prospective phase III study
P. Sonneveld, C.M. Segeren, B. van der Holt, E. Vellenga, A.J. Croockewit, G.E.G. Verhoef, J.J. Cornelissen, M.R. Schaafsma, P.W. Wijermans, S. Wittebol, H.C. Schouten, R. Slater, I. Buijt, P. Westveer, M. Steijaart, H.M. Lokhorst (Rotterdam, The Netherlands)
|